Low baseline interleukin-17A levels are associated with better treatment response at 12 weeks to tocilizumab therapy in rheumatoid arthritis patients

Sang Jin Lee, Won Park, Sung Hwan Park, Seung Cheol Shim, Han Joo Baek, Dae Hyun Yoo, Hyun Ah Kim, Soo Kon Lee, Yun Jong Leee, Young Eun Park, Hoon Suk Cha, Jin Kyun Park, Eun Young Lee, Eun Bong Lee, Yeong Wook Song

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Low baseline interleukin-17A levels are associated with better treatment response at 12 weeks to tocilizumab therapy in rheumatoid arthritis patients'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology